Portola Valley, CA, United States of America

Jane S Lebkowski

This inventor holds 20 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Rhone-Poulenc Rorer Pharmaceuticals Inc., Asterias Biotherapeutics, Inc., Applied Immunesciences, Inc.. Active years: 1992-2021.

USPTO Granted Patents = 20 (Patent Applications = 5)

% Patents Active = 80.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 769(Granted Patents)

Company Filing History:

6 out of 111

Rhone-Poulenc Rorer Pharmaceuticals Inc.

patents

5 out of 23

Asterias Biotherapeutics, Inc.

patents

4 out of 17

Applied Immunesciences, Inc.

Aventis Pharmaceuticals Inc.

patents

6. 1 out of 2,369

Regents of the University of Minnesota

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11123374 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2021-09-21),

2. 10344262 - Differentiation of primate pluripotent stem cells to hematopoietic lineage cells (2019-07-09),

3. 10286009 - Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury (2019-05-14),

4. 9074182 - Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes (2015-07-07),

5. 9023645 - Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cells (2015-05-05),

6. 8426198 - In vitro differentiated cell and human embryonic stem cell population (2013-04-23),

7. 8323966 - Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes (2012-12-04),

8. 8093049 - Differentiation of primate pluripotent stem cells to hematopoietic lineage cells (2012-01-10),

9. 6652850 - Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity (2003-11-25),

10. 6576464 - Methods for providing differentiated stem cells (2003-06-10),

11. 5861314 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

12. 5861171 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

13. 5834441 - Adeno-associated viral (AAV) liposomes and methods related thereto (1998-11-10),

14. 5807686 - Pluripotential quiescent stem cell population (1998-09-15),

15. 5780280 - Recombinant adeno-associated virus vectors (1998-07-14),

Title: The Innovative Journey of Jane S Lebkowski

Introduction: Jane S Lebkowski is a pioneering inventor based in Portola Valley, California. Her groundbreaking work in the field of biotechnology has led to numerous patents and advancements in the medical industry.

Latest Patents: Jane S Lebkowski holds several patents related to stem cell research and regenerative medicine, showcasing her commitment to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning several decades, Jane S Lebkowski has held key positions in various biotech companies, contributing significantly to the development of cutting-edge therapies and treatments. Her expertise in molecular biology and cell therapy has been instrumental in shaping the future of healthcare.

Collaborations: Throughout her career, Jane S Lebkowski has collaborated with leading researchers, scientists, and medical professionals to further the field of regenerative medicine. Her collaborative spirit and innovative approach have resulted in groundbreaking discoveries that have the potential to revolutionize the medical landscape.

Conclusion: Jane S Lebkowski's dedication to innovation and her relentless pursuit of scientific excellence have cemented her reputation as a trailblazer in the field of biotechnology. Her work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of medical science.